GKOS - Glaukos Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GKOS is currently covered by 12 analysts with an average price target of $117.91. This is a potential upside of $22.48 (23.56%) from yesterday's end of day stock price of $95.43.

Glaukos Corp's activity chart (see below) currently has 185 price targets and 190 ratings on display. The stock rating distribution of GKOS is 78.57% BUY, 20% HOLD and 1.43% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 83.77% with an average time for these price targets to be met of 128.11 days.

Highest price target for GKOS is $176, Lowest price target is $140, average price target is $142.64.

Most recent stock forecast was given by ANTHONY PETRONE from MIZUHO on 16-Apr-2025. First documented stock forecast 22-Sep-2015.

Currently out of the existing stock ratings of GKOS, 55 are a BUY (78.57%), 14 are a HOLD (20%), 1 are a SELL (1.43%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$175

$84.74 (93.88%)

$200

8 days ago
(16-Apr-2025)

8/10 (80%)

$86.2 (97.07%)

70

Buy

$165

$74.74 (82.81%)

$180

9 days ago
(15-Apr-2025)

38/40 (95%)

$70.48 (74.57%)

128

Buy

$140

$49.74 (55.11%)

$185

13 days ago
(11-Apr-2025)

2/4 (50%)

$49.93 (55.43%)

106

Buy

$176

$85.74 (94.99%)

$137

2 months 3 days ago
(21-Feb-2025)

12/13 (92.31%)

$50.12 (39.82%)

110

Buy

$175

$84.74 (93.88%)

$153

3 months 24 days ago
(31-Dec-2024)

7/8 (87.5%)

$25.06 (16.71%)

97

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GKOS (Glaukos Corp) average time for price targets to be met?

On average it took 128.11 days on average for the stock forecasts to be realized with a an average price target met ratio 83.77

Which analyst has the current highest performing score on GKOS (Glaukos Corp) with a proven track record?

RICHARD NEWITTER

Which analyst has the most public recommendations on GKOS (Glaukos Corp)?

Richard Newitter works at TRUIST and has 69 price targets and 39 ratings on GKOS

Which analyst is the currently most bullish on GKOS (Glaukos Corp)?

David Saxon with highest potential upside - $85.74

Which analyst is the currently most reserved on GKOS (Glaukos Corp)?

Elemer Piros with lowest potential downside - -$47.26

Glaukos Corp in the News

Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30

Conference Call and Webcast Scheduled for 1:30 p.m. PT ALISO VIEJO, Calif., April 09, 2025–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release first quarter 2025 financial results after the market close on Wednesday, April...

What Makes Glaukos Corporation (GKOS) a Compelling Stock?

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The stock market performance in the first quarter of 2025 was volatile, following the initial “animal spirits” post-election rally. The strategy surpassed its benchmark with the support of...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?